Just reviewing on the year passing...on the 29 May 2017 we were down in the depths of despair...a patient had died and our trials were put on hold...The SP was approx 5c and continued at 5c and reached its low of 4.7 cents on the 18 Sept 2017 even though on the 4 September the AML trial was given the go ahead to restart.
On the 21 November Edison Research put a price on PTX of 29 c ...that was before the great result of the breast cancer trials...which caused the share to shoot to an intraday high of 18c before collapsing to 12c its highest day close was 14c...It is above that now and last week rose 2c on healthy volume.
There are 20 trading days left in June and if the options are exercised...and the Edison Report mentioned PTX needed about $6 million in FY19 to continue the trials...IF the options were exercised the medium term risk of financing would be taken away..,IF the AML trials were successful or any of the others tPTX will be in for some serious price appreciation.
PTX Price at posting:
14.0¢ Sentiment: Buy Disclosure: Held
